*1.Contact Information:(Required.)

First Name:

Last Name:

Email:

Organization:

*2.Which of the following best describes your current institution/company/organization?(Required.)

Pharma/Biotechnology

CRO/CMO/CDMO

Research Institute (for-profit)

Research Institute/Foundation (non-profit)

Academic/University

Government

Distributor

If other, please specify

*3.What are your current challenge(s) in cell models and associated media/reagents purchased from ATCC? (Select all that apply)(Required.)

Cell viability/recovery post thaw of ATCC vials

Time and cost for cell expansion based on ATCC vial format

Contamination and other technical issues in starting cultures

Lack of product or technical support from ATCC

Poor application data support for product

Time to order from ATCC

Complicated paperwork/order process from ATCC

Cost of ATCC products

Limited product offerings of media and reagents directly available from ATCC

If other, please specify

*4.Which of the following definitions best matches your understanding of an "advanced in vitro model"? (Please select only one)(Required.)

(Core/Minimal): Human-cell–based in vitro systems engineered to better recapitulate key aspects of tissue/organ structure and function than conventional 2D monocultures, enabling more physiologically relevant measurements.

(Function-first): In vitro systems with demonstrated, measurable functional performance aligned to a defined context of use (COU), providing improved human relevance over conventional cell culture.

(Systems-level): In vitro models that incorporate multiple cell types and/or microenvironmental features (e.g., ECM, flow, mechanics) to reproduce tissue-level function and enable more predictive testing.

(Broad NAM-aligned): Advanced in vitro platforms (including organoids, iPSC-derived tissues, and microphysiological systems) designed for human-relevant biology with standardized performance metrics and fit-for-purpose validation.

*5.For each model system below, indicate whether it should be considered an "Advanced In Vitro Model."(Required.)

Yes

No

Not Sure

2D monoculture (immortalized line)

Yes

No

Not Sure

2D primary cells (monoculture)

Yes

No

Not Sure

Co-culture in 2D (two cell types)

Yes

No

Not Sure

3D spheroids (single cell type)

Yes

No

Not Sure

3D spheroids (multi-cell type)

Yes

No

Not Sure

Organoids (stem-cell derived)

Yes

No

Not Sure

iPSC-derived differentiated tissues (2D)

Yes

No

Not Sure

iPSC-derived 3D tissues/organoids

Yes

No

Not Sure

Organ-on-chip / MPS with flow

Yes

No

Not Sure

Bioprinted tissues

Yes

No

Not Sure

Ex vivo tissue slices

Yes

No

Not Sure

*6.Which digital biology capabilities do you use today or expect to use most? (Select up to 2)(Required.)

Reference genomes & sequence data

Digital biological reference atlases (e.g., immune systems, PBMC based datasets, organoids)

Multi omics integration

Data provenance & traceability

AI / ML model training using biological datasets

*7.What would be most helpful from ATCC in the next 3–6 months?(Required.)

A “starter kit” resource page for early-career cell culture workflows

Quick model-selection guidance (what to use when)

Short “how-to” application notes (1–2 pages)

Live or on-demand training/webinars

Promotions/discounts for commonly used models

Other